In the BioHarmony Drug Report Database
Norgestimate
Prefest (norgestimate) is a small molecule pharmaceutical. Norgestimate was first approved as Prefest on 1999-10-22. It is used to treat amenorrhea, female infertility, and uterine hemorrhage in the USA. It is known to target short transient receptor potential channel 3 and short transient receptor potential channel 6.
Trade Name
|
Prefest |
|---|---|
Common Name
|
norgestimate |
ChEMBL ID
|
CHEMBL1200934 |
Indication
|
amenorrhea, female infertility, uterine hemorrhage |
Drug Class
|
Progestins |
Image (chem structure or protein)